OLMA

Olema Pharmaceuticals, Inc. Common Stock
Data: 2026-08-24

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Quick Stats
Aug 24, 2026

48.5

AI Score

HOLD

0.35

Volume Ratio

TBA

Next Earnings

13

+ve Days (30d)

16

-ve Days (30d)

OLMA Stock Summary

Last updated Aug 24, 2026

OLMA is currently trading at $10.49, positioned below its 200-day moving average of $17.62, suggesting bearish momentum. The stock has a 52-week range of $5.36 to $36.2591.

Technical Analysis: The 50-day moving average stands at $11.3, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.783, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.051, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates OLMA at 48.5/100 with a HOLD recommendation.

OLMA (Olema Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Aug 24, 2026

Indicator Value
RSI(14) 41.783
CMF (20) 0.051
ROC (10) -11.809
ADX (14) 26.894
Indicator Value
MACD (12,26,9) -0.258
AROONOSC (14) -21.429
WILLAMS %R (14) -66.932
MFI (14) 45.103
OLMA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

OLMA Price vs Max Options Open Interest
OLMA Max Change In Options Open Interest

OLMA Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OLMA Daily Out of Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OLMA Daily In the Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OLMA Most Active Options by Volume(near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Olema Pharmaceuticals, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

OLMA Moving Averages Analysis

OLMA (Olema Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 24, 2026

Days MA
10 10.69
20 11.17
30 11.32
50 11.3
100 12.68
200 17.62

OLMA Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 953.7 million
Earnings/Share ($) -2.04
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.423
EPS Estimate Next Year ($) -2.6884
WallStreet Target Price ($) 39.30
Most Recent Quarter